These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 11680113)
21. Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT). Wiersinga WJ; Bonten MJ; Boersma WG; Jonkers RE; Aleva RM; Kullberg BJ; Schouten JA; Degener JE; van de Garde EMW; Verheij TJ; Sachs APE; Prins JM Neth J Med; 2018 Jan; 76(1):4-13. PubMed ID: 29380739 [TBL] [Abstract][Full Text] [Related]
26. Risk factors and antibiotic therapy in P. aeruginosa community-acquired pneumonia. Sibila O; Laserna E; Maselli DJ; Fernandez JF; Mortensen EM; Anzueto A; Waterer G; Restrepo MI Respirology; 2015 May; 20(4):660-6. PubMed ID: 25776134 [TBL] [Abstract][Full Text] [Related]
27. Getting physicians to make "the switch": the role of clinical guidelines in the management of community-acquired pneumonia. Hagaman JT; Yurkowski P; Trott A; Rouan GW Am J Med Qual; 2005; 20(1):15-21. PubMed ID: 15782751 [TBL] [Abstract][Full Text] [Related]
29. Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting. Segreti J; House HR; Siegel RE Am J Med; 2005 Jul; 118 Suppl 7A():21S-28S. PubMed ID: 15993674 [TBL] [Abstract][Full Text] [Related]
30. Management of community-acquired pneumonia by trained family general practitioners. Potena A; Simoni M; Cellini M; Cartabellotta A; Ballerin L; Piattella M; Putinati S Int J Tuberc Lung Dis; 2008 Jan; 12(1):19-25. PubMed ID: 18173872 [TBL] [Abstract][Full Text] [Related]
31. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission. Reyes Calzada S; Martínez Tomas R; Cremades Romero MJ; Martínez Moragón E; Soler Cataluña JJ; Menéndez Villanueva R Respir Med; 2007 Sep; 101(9):1909-15. PubMed ID: 17628462 [TBL] [Abstract][Full Text] [Related]
32. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Charles PG; Whitby M; Fuller AJ; Stirling R; Wright AA; Korman TM; Holmes PW; Christiansen KJ; Waterer GW; Pierce RJ; Mayall BC; Armstrong JG; Catton MG; Nimmo GR; Johnson B; Hooy M; Grayson ML; Clin Infect Dis; 2008 May; 46(10):1513-21. PubMed ID: 18419484 [TBL] [Abstract][Full Text] [Related]
33. Epidemiology of clinically diagnosed community-acquired pneumonia in the primary care setting: results from the 1999-2000 respiratory surveillance program. Gotfried MH Am J Med; 2001 Dec; 111 Suppl 9A():25S-29S; discussion 36S-38S. PubMed ID: 11755440 [TBL] [Abstract][Full Text] [Related]
34. Comparative effectiveness of empiric β-lactam monotherapy and β-lactam-macrolide combination therapy in children hospitalized with community-acquired pneumonia. Ambroggio L; Taylor JA; Tabb LP; Newschaffer CJ; Evans AA; Shah SS J Pediatr; 2012 Dec; 161(6):1097-103. PubMed ID: 22901738 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Singanayagam A; Aliberti S; Cillóniz C; Torres A; Blasi F; Chalmers JD Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28890433 [TBL] [Abstract][Full Text] [Related]
36. [Optimizing the antibiotics policy in The Netherlands. VIII. Revised SWAB guidelines for antimicrobial therapy in adults with community-acquired pneumonia]. Schouten JA; Prins JM; Bonten M; Degener JE; Janknegt R; Hollander JM; Jonkers R; Wijnands W; Verheij T; Sachs A; Kullberg BJ Ned Tijdschr Geneeskd; 2005 Nov; 149(45):2495-500. PubMed ID: 16304886 [TBL] [Abstract][Full Text] [Related]